OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

← The Leprosy Mission International

2024-12-31-accounts

THE LEPROSY MISSION Annual Report and Financial Statements 2024

Charity registration number 1076356

Company registration number 03591514 (England and Wales)

THE LEPROSY MISSION INTERNATIONAL ANNUAL REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024

THE LEPROSY MISSION INTERNATIONAL

LEGAL AND ADMINISTRATIVE INFORMATION

Trustees Professor E I Braide
Mrs C H H Aye
Dr J W Britton
Mr G H Brown
Mrs F A Davidson (Appointed 18 November 2024)
Mrs A Delhaas
Mrs A C Fendick (Appointed 18 March 2025)
Mr A D Gray
Ms O J Habets
Dr C L Martin
Mr C Osborne
Dr D Prasad
Mr L Thapa
Secretary Mr B J Morgan
Charity number 1076356
Company number 03591514
Registered office 80 Windmill Road
Brentford
Middlesex
United Kingdom
TW8 0QH
Auditor Azets Audit Services
Westpoint
Lynch Wood
Peterborough
Cambridgeshire
United Kingdom
PE2 6FZ
Bankers Barclays Bank Plc
8 George Street
Richmond
Surrey
TW9 1JU
Pension Scheme Actuaries First Actuarial LLP
Network House
Basing View
Basingstoke
Hampshire
RG21 4HG
Investment advisors Rathbone Investment Management Ltd
8 Finsbury Circus
London
EC2M 7AZ

THE LEPROSY MISSION INTERNATIONAL

CONTENTS

Page
Trustees' report 1 - 19
Independent auditor's report 20 - 22
Statement of financial activities 23 - 24
Balance sheet 25
Statement of cash flows 26
Notes to the financial statements 27 - 52

THE LEPROSY MISSION INTERNATIONAL

A Company Limited by Guarantee, Registered Company Number: 3591514

Registered Charity Number: 1076356

Registered Office Address and Principal Place of Business: 80 Windmill Road, Brentford, Middlesex, TW8 0QH England

REPORT OF THE TRUSTEES (INCORPORATING THE STRATEGIC REPORT)

The Trustees who are also directors of the company have pleasure in presenting their Report and Financial Statements for the year ended 31 December 2024, prepared in accordance with the Statement of Recommended Practice (FRS 102) and the Companies Act 2006. The Report of the Trustees incorporates the requirements of the Strategic Report.

The Leprosy Mission International (‘the Mission’) is an interdenominational Christian organisation, founded in 1874. The Charity receives much of its support from Supporting Countries and Support Groups who work in partnership with The Leprosy Mission International. Each part of The Leprosy Mission (TLM) recognises and values their interdependence and mutual support for each other in their joint ministry to people affected by leprosy.

MISSION STATEMENT

Following Jesus Christ, The Leprosy Mission seeks to bring about transformation; breaking the chains of leprosy, empowering people to attain healing, dignity and life in all its fullness.

OUR VISION

We are committed to our vision of “Leprosy defeated, lives transformed”.

OUR AREAS OF STRATEGIC FOCUS

Zero Leprosy Transmission

Zero transmission of leprosy by 2035 as a result of earlier detection and treatment of new leprosy cases.

Towards Zero Leprosy Disability

Healing, dignity and life in all its fullness as a result of a) reduced disability burden in people affected by leprosy and b) the transformation of physical, mental, emotional and spiritual wellbeing of people affected by leprosy.

Towards Zero Leprosy Discrimination

Zero discrimination against people affected by leprosy as a result of a) the greater inclusion of, and justice for, people affected by leprosy and disability and b) people affected by leprosy confidently standing up for their rights.

Christ-centred

Transformation and Life in all its Fullness for people affected by leprosy.

The Leprosy Mission Enabled

An agile TLM with Members and people who are resilient, stronger, healthier and more sustainable; raising £40 million per annum; a renewed global, national and local commitment to defeating leprosy and promoting inclusion; with TLM known as a leading collaborative player.

OUR VALUES

Because we follow Jesus Christ we value Compassion, Justice, Integrity, Inclusion and Humility.

Transformation involves body, mind and spirit. In all we do, through prayer and obedience to God, we want to proclaim and demonstrate the truth and love of Jesus Christ.

1

THE LEPROSY MISSION INTERNATIONAL REPORT OF THE TRUSTEES

STRUCTURE, GOVERNANCE AND MANAGEMENT

The Leprosy Mission International is governed by the Memorandum and Articles of Association dated 24 September 2021 and the Trustees of the Mission are appointed by the members. The Trustees of the Mission are Directors for the purposes of company law.

The current organisation structure is as follows:

The Leprosy Mission International is the leading and coordinating body for The Leprosy Mission Fellowship, an unincorporated partnership of entities operating in the name of The Leprosy Mission in 27 countries. The members of The Leprosy Mission International are also the Members of The Leprosy Mission Fellowship and a meeting of members is held each year. The Board is the governing body of The Leprosy Mission International. During the year it has met four times, in April, July, September and November. All Board members (Trustees) are non-salaried.

The Representative Management Group is an advisory group which functions through the International Director, who is the chief executive and reports to the Board. The group comprises eight members who have specific functions within The Leprosy Mission Fellowship.

Two committees operate under the delegated authority of the Board and report to the Board:

Audit Committee (Chairperson: Mr Gordon Brown)

The Audit Committee advises the Board on the quality and effectiveness of the programmes of the Mission, the nature and extent of the major risks associated with the implementation of those programmes and the ‐ integrity of financial and non financial management and reporting in the Mission. During the year, the Audit Committee met four times, in April, July, September and November. The Audit Committee recommended the attached Financial Statements to the Board for approval.

Governance Committee (Chairperson: Mr Colin Martin)

The Governance Committee is responsible for ensuring that suitable candidates with appropriate skills are brought forward for election to serve as Trustees, for ensuring that the Board’s policies are reviewed on a regular basis, and for monitoring the effectiveness of the Board having regard to best practice in organisational governance. Newly appointed Trustees are given an orientation to the Mission and a Board manual comprising the Memorandum, Articles and Bye Laws of the Mission and all relevant policies, guidelines and procedures. During the year, the Committee met four times, in April, July, September and November.

The Directors (Trustees) of the charitable company throughout the year are as follows:

2

THE LEPROSY MISSION INTERNATIONAL REPORT OF THE TRUSTEES

STRUCTURE, GOVERNANCE AND MANAGEMENT (continued)

INTERNATIONAL DIRECTOR AND COMPANY SECRETARY

Mr Brent J Morgan

RISK MANAGEMENT

Risk reviews were conducted during the year and potential areas of risk were identified and reported to the Board.

Through the risk management processes and controls established for the charity, the Trustees assess business risks annually and are satisfied that the major risks are identified and assessed and that systems are in place to mitigate the charity’s exposure to these risks. It is recognised that systems can only provide reasonable assurance that major risks have been adequately managed. Given the nature and geographical location of the programmes, there will always be some element of risk although the Mission attempts to minimise these wherever possible, by regular tele-conference and face-to-face meetings.

The Trustees identified the following major risks:

The Trustees continue to monitor the changing global landscape and its impact on the Mission.

REMUNERATION OF KEY MANAGEMENT PERSONNEL

The Trustees consider the Board of Trustees, the International Director of the Mission and the Chief Executive Officer of TLM Trading to comprise the key management personnel of the group.

All Trustees give of their time freely and no director received remuneration in the year.

The pay of the key management personnel and all staff are reviewed annually and normally increased in accordance with average earnings to reflect a cost of living adjustment. In view of the nature of the charity, the Trustees benchmark against pay levels in other similar charities.

POLICIES

Grant Making

Grants are given annually to programmes which fit the vision and strategy of the Mission. All approved programmes are required to complete annual plans and budgets. The programmes also prepare annual rolling budgets for their duration or for five years maximum. Grants are paid in accordance with the approved budget, which includes annual objectives and projects’ long-term goals. Each programme is thoroughly considered by the country office to ensure both feasibility and effectiveness before being reviewed in accordance with the Programme Approval Policy.

Programmes are then monitored throughout the life of the project by the relevant country office and come under the scrutiny of regular internal audit and an evaluation process.

3

THE LEPROSY MISSION INTERNATIONAL

REPORT OF THE TRUSTEES

POLICIES (Continued)

Investment

Management of the funds is conducted in accordance with the Articles of Association and within agreed policies and guidelines set and monitored by the Audit Committee.

Specific ethical guidelines have been given to the investment managers to avoid investment in companies significantly involved in alcohol, tobacco products, gambling, armaments or pornography, and also to consider the Environmental, Social and Governance (ESG) methods of any company which might contravene the objectives and values of the Mission. The performance of the fund is measured against an asset allocation of equal split between UK equities and bonds and overseas equities and bonds (see page 12). Investment decisions are based upon long- term considerations and on a total return basis.

The investment manager is appointed under the delegated authority given to the Audit Committee and their performance is reviewed on a rolling three year cycle. Rathbone Investment Management Limited were appointed as investment managers.

Safeguarding

The Leprosy Mission takes safeguarding seriously and has global and local policies and procedures in place, which are regularly reviewed. We have a zero-tolerance approach to serious misconduct.

The Leprosy Mission has policies, procedures and guidelines, including but not restricted to:

Safeguarding is a standing item in the TLMI Board agenda and in Member countries Boards agendas. We have continued our commitment to upholding the highest standards of safeguarding, ensuring that our safeguarding measures are robust and reflect the environments in which we work. We have continued to broaden our approach, increasing our ability to safeguard staff, the adults we work with and volunteers, while remaining steadfastly committed to safeguarding children.

4

THE LEPROSY MISSION INTERNATIONAL REPORT OF THE TRUSTEES

POLICIES (Continued)

During 2024, The Leprosy Mission International received seven safeguarding concerns – the allegations made were related to; four for sexual harassment, one for sexual abuse, one for bullying, and one related and signposted as an HR grievance, of which six were substantiated, one was not investigated as it fell out of TLM remit. One of the seven concerns received was deemed a serious incident and was reported to the Charity Commission of England and Wales. The Leprosy Mission continues to collect learning from these reports and endeavours to make the necessary changes to our policy and practice to ensure, we proactively protect the dignity and rights of every person.

Management

The Board-appointed International Director is responsible for strategy, planning and the daily management of operations. The International Director is supported by a senior leadership team who have delegated authority for key aspects of the Mission’s operations.

The International Director reports to the Trustees on progress against the indicators and targets in the Global Strategy. The International Director and appropriate members of the senior leadership team attend and report at meetings of sub-committees.

A five-year strategy for The Leprosy Mission was developed to ensure that the work of The Leprosy Mission is working towards achieving Zero Leprosy Transmission, Zero Leprosy Disability and Zero Leprosy Discrimination. Implementation commenced in 2019, the progress is discussed within the Achievements and Performance.

There is a policy for the setting of the remuneration of the International Director. The Chair of Trustees in conjunction with Head of People appraise the International Director’s performance annually and establish any increase in line with the Consumer Price Index (CPI) which applies to all staff.

The systems of internal control are designed to provide reasonable but not absolute assurance against misstatement or loss. These include:

Employment of People Affected by Leprosy and People with Disabilities

Globally, The Leprosy Mission employs numerous staff who have been personally affected by leprosy. This is estimated at between five and ten per cent of the total number of staff. In 2024, The Leprosy Mission International employed one staff affected by leprosy and actively encouraged people with disabilities with appropriate skills and experience to apply for vacant positions. There is one person affected by leprosy serving as a Trustee.

Staff Development

Training and developing our staff remain a key activity as The Leprosy Mission International (and the TLM Global Fellowship) strives to serve those affected by leprosy. We developed a tailor-made leadership development programme which incorporates a number of leadership skills development training using external providers. The programme is aimed at training all senior leaders and second tier leaders within the organisation.

5

THE LEPROSY MISSION INTERNATIONAL REPORT OF THE TRUSTEES

POLICIES (Continued)

Reserves

In determining the level of operational reserves, the Board recognises the global organisation’s need for centrally invested reserves to provide operating capital and as a contingency or hardship fund to support members to overcome short-term financial challenges. The Board has set a policy range for the reserves taking into account factors that include: the unpredictability of exchange rates, donor income and investment values and the potential impact of these events upon our programmes (refer to page 12).

Monitoring

Against each of the medium to long-term strategies the Board has identified a number of targets/indicators which need to be met. The organisation monitors the effectiveness of the strategy on an annual basis and reports its findings to the Board to ensure that the organisation achieves the target which has been set.

Public Benefit Statement

The Trustees of the charity have complied with the duty in Section 17 of the Charities Act 2011 to have due regard to public benefit guidance published by the Charity Commission and the work of The Leprosy Mission to further the public benefit is explained in this report.

OBJECTIVES AND ACTIVITIES

In September 2018, on the Board’s recommendation, the Members approved a five-year strategy. In considering the covid lockdown and its impact on the implementing activities, the Trustees approved the current strategy to be extended to the end of 2024.

Zero Leprosy Transmission

The Leprosy Mission Will:

We will work to improve:

6

THE LEPROSY MISSION INTERNATIONAL REPORT OF THE TRUSTEES

OBJECTIVES AND ACTIVITIES (Continued)

Impact by the End of 2024:

Earlier detection and treatment of new leprosy cases.

Our Future Ambition:

Zero transmission of leprosy by 2035.

Towards Zero Leprosy Disability

The Leprosy Mission Will:

We will work to improve:

Impact by the End of 2024:

Reduced disability burden in people affected by leprosy.

Transformation of physical, mental, emotional and spiritual wellbeing of people affected by leprosy.

Our Future Ambition:

Healing, dignity and life in all its fullness.

Towards Zero Leprosy Discrimination

The Leprosy Mission Will:

7

THE LEPROSY MISSION INTERNATIONAL REPORT OF THE TRUSTEES

OBJECTIVES AND ACTIVITIES (Continued)

We will work to improve:

Impact by the End of 2024:

Our Future Ambition:

Christ-centred

The Leprosy Mission Will:

Impact by the End of 2024:

Our Future Ambition:

8

THE LEPROSY MISSION INTERNATIONAL REPORT OF THE TRUSTEES

OBJECTIVES AND ACTIVITIES (Continued)

The Leprosy Mission Enabled

The Leprosy Mission Will:

We will work to improve:

Impact by the End of 2024:

ACHIEVEMENTS AND PERFORMANCE

The Trustees have identified a number of achievement indicators, based on the strategic plan, against which they monitor the performance of the organisation.

Organisational Activities

Advocacy (Zero Discrimination and enabling The Leprosy Mission’s work)

In the Trustees report for 2023, we reported that the Maltese parliament was due to repeal a law that discriminates on the grounds of leprosy. We are pleased to report that this law was repealed in 2024, marking one of the most significant advocacy wins of the year. Since repealing this law, the Government of Malta has become active partners in the work to repeal these discriminatory laws in countries across the world.

In 2024, The Leprosy Mission International hosted a side event at the United Nations’ CRPD Conference on the right to work and employment for persons with disabilities in low- and middle-income countries. The side event included a keynote speech from the UN’s Special Rapporteur on the rights of persons with disabilities, as well as contributions from the World Bank, UNESCWA, and civil society representatives. As well as this, The Leprosy Mission contributed to the General Debate at the conference through a short speech and to the Civil Society Forum.

9

THE LEPROSY MISSION INTERNATIONAL REPORT OF THE TRUSTEES

ACHIEVEMENTS AND PERFORMANCE (Continued)

Another item reported in the 2023 Trustees report was the formation of a Member-Appointed Working Group on the topic of advocacy. This group began work in 2024 and has already contributed significantly by supporting the inclusion of advocacy within The Leprosy Mission’s new Global Strategy and through the development of an Advocacy Toolkit, which will support TLM’s teams in delivering the advocacy components of the new Global Strategy.

We are pleased to report that it was through the engagement of the advocacy team at The Leprosy Mission International that persons affected by leprosy were engaged in the consultation process for the development of the new Global Strategy. Leaders of Organisations of Persons Affected by Leprosy from Asia and Africa were consulted throughout the strategy development process.

Income (Enabling The Leprosy Mission’s work)

In 2024, total donation income was £16,172,608 (2023: £17,647,585) which was a decrease of 8% compared to previous year. This was a remarkable income performance given the global economic slowdown and global political unrest through 2024. Our Global Income in 2024 reached £41,385,468, which is above the target set in the Global Strategy (2019 to 2024).

Public Health (Zero disability and zero transmission)

In almost all the countries where we work, leprosy services have been integrated into mainstream health care, which is important for reducing stigma and to make leprosy treatment sustainable. However, one of the consequences has been less attention to leprosy: the number of new cases has ceased to fall and there is the risk in some areas with weaker health services that new cases will begin to increase.

The Leprosy Mission still provides effective training to government medical staff to ensure that people affected by leprosy are given the high-quality treatment they need. In 2024 we gave technical assistance to governments in more than 13 countries. We also provided at least 59,078 training days for TLM staff, government health staff and other NGOs in leprosy (2023: 66,329).

Hospitals (Zero disability and zero transmission)

In many countries, hospitals supported or owned by TLM are centres of excellence, providing specialised care to leprosy-affected people and appropriate forms of healthcare to the surrounding communities.

These community hospitals provide a variety of in- and out-patient services. Leprosy and non-leprosy patients are treated together which helps reduce stigma and segregation.

In 2024 we supported 16 TLM owned hospitals and another 8 partner hospitals. The hospitals provided 27,571 in-patients with care for leprosy related conditions (2023: 15,359). TLM increased a wide-range of patient-care services at our hospitals to meet their health needs over the years. We performed 1,301 reconstructive and eye surgeries related to leprosy (2023: 1,348).

During the current Strategic phase (2019 to 2024), we supported 71,202 in-patient care for people affected by Leprosy and performed 9,351 reconstructive and eye surgeries related to leprosy.

Disability care and prevention (Zero disability)

If leprosy is not diagnosed quickly enough, nerves are damaged and disability is an inevitable consequence. An estimated 2-3 million people are disabled due to leprosy.

Self-care groups provide an environment where people can share problems, encourage each other and learn how to look after themselves to prevent worsening disabilities.

In 2024 we provided assistance to 441 self-care groups, which included 5,699 participants (2023: 327 groups with 7,675 participants). Periodical visit by TLM trained health care workers have encouraged formation of more health care groups.

10

THE LEPROSY MISSION INTERNATIONAL REPORT OF THE TRUSTEES

ACHIEVEMENTS AND PERFORMANCE (Continued)

In 2024 TLM provided 23,661 people (2023: 27,018) with footwear and orthopaedic devices to protect their insensitive feet from further damage or disability. Less funding was available to disability management and rehabilitation in the year.

During the current Strategic phase (2019 to 2024), we provided 136,520 people with footwear and orthopaedic devices to protect their insensitive feet from further damage or disability.

Community development (Zero discrimination)

Leprosy is not just a physical disease, it has social consequences. Therefore community development is an important part of TLM’s work. We encourage leprosy-affected people to set up local community or disability groups; together they can save money and come up with plans for improving their communities and increasing their income. In some countries these self-help groups are amalgamated into larger cooperatives to better meet their members’ needs.

In 2024 we supported 2,308 self-help groups and cooperatives with 29,062 participants (2023: 2,538 groups with 34,224 participants). During the year we saw Self Help Groups merged to Associations and national bodies, this enables greater voice and visibility.

In 2024 we built or renovated 292 low-cost homes (2023: 115) for leprosy-affected people in poverty. Local government assisted in a number of areas we work in providing housing and/or renovation of patients’ existing houses. We enabled 159,503 people to access new or renovated water or sanitation facilities (2023: 8,769). TLM DRC received funds to support many communities with WASH projects that led to decrease in disease caused by lack of hygiene practices and water borne disease.

During the current Strategic phase (2019 to 2024), we built 2,026 low-cost homes for leprosy-affected people and enabled 192,243 people to access new or renovated water or sanitation facilities.

Education (Zero discrimination)

Training and education provide leprosy-affected people and their families a means to break free from the cycle of poverty. In 2024 we provided scholarships for formal education to 5,299 children or young people (2023: 3,730). Children in formal education were able to access funding from government of India. We provided vocational training or apprenticeships to 4,522 young people (2023: 6,056).

At TLM’s own Vocational Training Centres in India we trained 1,942 young people in marketable skills, setting them up for life (2023: 2,948). Some courses were withdrawn in the year. During the current Strategic phase (2019 to 2024), we trained 20,831 young people in marketable skill, setting them for life.

Research (Zero transmission, zero disability, zero discrimination, and enabling The Leprosy Mission’s work)

In 2024, TLM conducted 38 (2023:42) research studies in seven countries (Bangladesh, DR Congo, India, Mozambique, Nepal, Niger and Nigeria). Most of our research relates to interrupting transmission (14 studies) and reducing disability (11 studies). Transmission research includes the development of point-of-care diagnostics tests, and testing of alternative chemoprophylaxis regimens. Disability research includes better treatment for leprosy reaction and innovative approaches to wound healing.

Church engagement (Christ-centred and Enabling The Leprosy Mission’s Work)

Our work is sustained by the prayerful giving of churches all across the world. Their support can come in the form of donations, volunteering, fundraising activities, and more. In total we have 7,284 (2023: 9,385) churches who are giving to our work.

11

THE LEPROSY MISSION INTERNATIONAL REPORT OF THE TRUSTEES

ACHIEVEMENTS AND PERFORMANCE (Continued)

Life in all its fullness (Christ-centred)

Our desire to see people living life in all its fullness is informed by a Bible verse. Jesus said “I have come in order that you may have life – life in all its fullness” (John 10:10). Through our self-help groups, livelihood support, and community development we are working to provide fullness of life for people affected by leprosy and people in communities affected by leprosy. However, we are also committed to ensuring that the staff of The Leprosy Mission worldwide are nurtured and encouraged so that they can live life in all its fullness. Our staff engagement work received again a recognition in 2024 granted by Agenda Consultancy for the number of staff who would recommend The Leprosy Mission as a place to work.

FINANCIAL PERFORMANCE

The consolidated surplus for the year was £193,241 (2023: £1,075,264) before reporting the unrealised gains and losses of investments. Remittances include £2,165,415 of restricted funds for Hospitals and Programmes which are carried over into 2025 and will be expended. Investment loss during the year was £433,705 (2023: gain of £127,053).

The Board is thankful for the continued support from TLM Fellowship Member Countries and other donor organisations. The field programmes are continuing to develop in line with the Mission’s strategy, giving increased focus on community programmes, which include both health development and rehabilitation. Many of the hospital programmes that the Mission supports provide services for non-leprosy patients, which in turn provide a local source of income for the hospital as well as providing general medical care to the local community.

Although TLMI does not directly engage in fundraising activity, TLMI has taken steps to strengthen support for Members who do. The appointment of Head of Fundraising Development was made with the specific intention to encourage and assist activities by Members to increase unrestricted donation income for Global Fellowship projects. This has been achieved, with the implementation of Fundraising Cycle (Ask-ThankFeedback) methodology by Fundraising member countries. We have received no complaints about fundraising and we have a complaint policy in place should any be received in the future.

Total expenditure of the charity in the year amounted to £12,093,311 (2023: £11,479,120) of which £9,636,711 (80%) (2023: £8,978,266) was attributable to charitable activities. Major programmes supported in 2024 are listed in Note 9 of the Accounts and they continue to represent a wide spread of activities across 16 countries.

Total support costs by the charity to TLM Fellowship Member countries are analysed in Note 8 of the accounts and amounts to 14% (2023: 12%) of the total income of the charity.

Investment

Rathbone Investment Management Ltd was re-appointed on 29 March 2021 as the investment manager. Their performance is monitored quarterly and on a rolling three-year basis. Trustees have set an investment strategy that reflect the following investment objectives; generating strong investment returns, managing cash flow requirements, protecting the financial position, minimising long term costs and ethical, environmental, social and governance considerations. The asset allocation would normally fall within 60% of Equity (UK/Overseas) and 40% of fixed interest (UK/Overseas). The investment manager is expected to outperform the benchmark given to him by the Audit Committee. The performance has been monitored by management and the Treasurer on a quarterly basis.

In the year ended 31 December 2024 the fund achieved a return of 4.7 % (2023: (10.9%)) against the benchmark of 7.4% (2023: (9.1%)).

12

THE LEPROSY MISSION INTERNATIONAL REPORT OF THE TRUSTEES

FINANCIAL PERFORMANCE (Continued)

Reserves Review

During the year the Board affirmed the continuing need to hold adequate reserves. The Board has approved a reserve policy with a number of components, which in combination result in a guideline operational reserve level to be between £3 million (minimum) and £4 million (maximum). The current reserve policy was agreed in 2021 and the next review will be done 2025. The free reserve level at 31 December 2024 is £5,669,203 (2023: £5,238,143). With the current global political climate, the Trustees are satisfied with the reserve level which is above the upper limit set by them. Further, for 2025, the Mission is working with a deficit budget of £(461,000). Trustees approved to spend £500,000 in 2024-25 from the reserves on projects that have innovative ideas/initiatives to achieve the goal of “Zero Leprosy transmission by 2035”

In addition, an amount of £4,444,298 is held in bank and investments as restricted funds listed in Note 24. An amount of £1,632,517 is held as designated funds as listed in Note 23.

Going Concern

The directors have assessed whether the use of the going concern assumption is appropriate in preparing these accounts. The directors have made this assessment in respect to a period of one year from the date of approval of these accounts. After reviewing the company’s forecasts and projections, which are being regularly updated, the directors are of the opinion that the company will have sufficient resources to meet its liabilities as they fall due.

The Board of Trustees consider that there are no material uncertainties with respect to going concern and accordingly, the directors continue to adopt the going concern basis in preparing these financial statements.

Accordingly, the Board of Trustees is of the opinion that the charity has adequate resources to continue in operational existence for the foreseeable future.

Subsidiary Company

TLM Trading Limited is a wholly owned subsidiary of The Leprosy Mission International and its results for the year have been consolidated with those of The Leprosy Mission International and reported in the Financial Statements.

TLM Trading Limited has three main objectives which are integral to the work of the Mission. The first objective is to raise financial support for The Leprosy Mission. The second objective is to develop products produced by people affected by leprosy and to sell these products to customers and the third is to raise the profile of The Leprosy Mission through all of the trading activities.

In 2024, the income of the trading company was £1,754,002 (2023: £1,822,449) and the company made a loss before taxation, before pension deficit liability of £(12,714) (2023: £19,180). Customers of TLM Trading Limited donated an amount of £626,997 (2023: £542,248) to TLM Supporting Countries through donations and Gift for Life.

Special Pension Account

A lump sum of £1 million was paid into an escrow account on 11 January 2012. Under the terms agreed release of funds from the escrow account to The Leprosy Mission Central Pension Scheme or to the employer would occur after an actuarial valuation when the funding level of the scheme reaches below 80% or combined funding level exceeds 108%. The Scheme actuary would issue a release notice with an amount sufficient to either increase the funding level of the scheme to 80% or to reduce the value to 108% of the statutory funding objectives.

The Leprosy Mission International (Principal Employer) and the Trustees agreed by Deed dated 30 June 2015 that the assets held in the escrow account would transfer to a Special Pension Account to be held by The Leprosy Mission International under similar terms to the escrow account. By agreement with the Pension Fund Trustees, The Leprosy Mission International agreed to pay pension contribution into the Special Pension Account.

13

THE LEPROSY MISSION INTERNATIONAL REPORT OF THE TRUSTEES

FINANCIAL PERFORMANCE (Continued)

The results of the 31 December 2021 triennial valuation showed that the Combined Funding Level of the Scheme was 141% and that the excess funds above the 108% trigger were £7,655,000. The Trustees and the Employers agreed that a refund of £1,080,000 would be taken by TLMI on behalf of all the Employers and will be paid in equal quarterly instalments of £90,000 over a three year period from 1 January 2023.

FUTURE PLANS

Global Strategy

The Leprosy Mission is currently working towards a Global Strategy that runs from 2025-2030.

Our strategic goals

Following the review of our previous strategy, we have a renewed commitment to the triple-zero goals: zero transmission, zero disability and zero discrimination. All three of these areas are critical, and none can be achieved without the others. Therefore, we have aspirational goals for each area. By 2035 in the countries where we work:

  1. Leprosy transmission will be interrupted

  2. Persons affected by leprosy will have prompt and appropriate access to services to prevent and manage leprosy disabilities

  3. Persons affected by leprosy will be included in society and will have equal access to their full rights and entitlements

To achieve these three aspirational goals, all of our Member Countries are committed to raising funds and have a responsibility to ensure that we will have sufficient and sustainable funding. The breakthroughs that will allow us to achieve our goals:

To succeed in our mission to defeat leprosy and transform lives, our Members will work together on four significant breakthroughs, which will be collectively funded. Each breakthrough area will be supported through the work of a Task Force comprised of subject-matter experts from across The Leprosy Mission.

  1. For Zero Transmission : Research, develop, and implement evidence-based tools to interrupt the transmission of leprosy, especially early diagnostic tests and post-exposure prophylaxis.

  2. For Zero Disability : Research, develop, and implement appropriate treatment regimens to address leprosy-related complications, especially treating leprosy reactions.

14

THE LEPROSY MISSION INTERNATIONAL REPORT OF THE TRUSTEES

FUTURE PLANS (Continued)

  1. For Zero Discrimination : Partner with, support and connect organisations of persons affected by leprosy to achieve greater inclusion and the reduction of discrimination.

  2. Funding : Identify and invest in growth markets (existing and new), funding sources and fundraising innovation to help achieve the income target (£60m by 2030) and ensure that the TLM Global Fellowship breakthroughs are funded to completion.

The organisational strengths that will allow us to achieve our goals:

It will take many organisations and governments working together to defeat leprosy. There are four distinctive strengths The Leprosy Mission’s Global Fellowship brings to this calling:

  1. Our Christian identity enables us to mobilise churches to fundraise and serve their local communities.

  2. Our global scale, yet community presence, empowers us to collaborate with United Nations agencies, international networks, governments, locally led organisations, churches, and especially organisations of persons affected by leprosy.

  3. Our medical and research expertise and infrastructure alongside our community presence enables us to develop, trial, and implement innovations in leprosy transmission, treatment and care.

  4. Our leprosy focus and work alongside persons affected by leprosy enables us to work with local leaders and communities to find solutions to even the most entrenched challenges

Our ways of working: To maximise the likelihood of having a sustainable impact, the TLM Global Fellowship strives to always deliberately focus on four ways of working:

Collaboration and Partnership : Together with persons affected by leprosy, we mobilise stakeholders at local, national and global level to plan, implement, and review our operations to ensure ownership and sustainability. This includes integrating approaches in our operations, especially with the other NTDs and disability programmes.

Programmatic Innovation : We mobilise local knowledge by implementing new ideas that add impact to the work we do with our stakeholders.

Applied Research : We invest in research dissemination and ensure that field clinicians, health personnel, partners and communities will apply learning and research findings in our local programmes.

Advocacy : At local, national, and global level contributes to successful partnership, innovation, and research; it amplifies the voices of persons affected by leprosy; and supports the successful implementation of the TLM Global Fellowship’s four breakthrough areas by contributing to policy change.

Zero Transmission

Under our 2025-2030 Global Strategy, we are working towards a goal of interrupting the transmission of leprosy in the countries we work in.

To succeed in this mission for leprosy transmission, our Members will work together on a breakthrough area that will be collectively funded:

Research, develop, and implement evidence-based tools to interrupt the transmission of leprosy, especially early diagnostic tests and post-exposure prophylaxis.

15

THE LEPROSY MISSION INTERNATIONAL REPORT OF THE TRUSTEES

FUTURE PLANS (Continued)

Beyond this, our Member countries will focus on a set of initiatives that are designed to achieve the interruption of leprosy transmission. Each country will work towards the initiatives that will have the most impact in their context. These initiatives are:

Zero disability

Under our 2025-2030 Global Strategy, we are working towards a goal of ensuring persons affected by leprosy will have prompt and appropriate access to services to prevent and manage leprosy disabilities . To succeed in this mission for leprosy disability, our Members will work together on a breakthrough area that will be collectively funded:

Research, develop, and implement appropriate treatment regimens to address leprosy-related complications, especially treating leprosy reactions.

Beyond this, our Member countries will focus on a set of initiatives that are designed to ensure prompt and appropriate access to services to prevent and manage leprosy disabilities.

Each country will work towards the initiatives that will have the most impact in their context. We will work with local and national governments, other service providers, and persons affected by leprosy to ensure:

16

THE LEPROSY MISSION INTERNATIONAL REPORT OF THE TRUSTEES

FUTURE PLANS (Continued)

Zero Discrimination

Under our 2025-2030 Global Strategy, we are working towards a goal of ensuring persons affected by leprosy will be included in society and will have equal access to their full rights and entitlements.

To succeed in this mission for leprosy discrimination, our Members will work together on a breakthrough area that will be collectively funded:

Partner with, support and connect organisations of persons affected by leprosy to achieve greater inclusion and the reduction of discrimination.

Beyond this, our Member countries will focus on a set of initiatives that are designed to ensure inclusion and equal access to rights and entitlements for persons affected by leprosy.

Each country will work towards the initiatives that will have the most impact in their context. We will be supporting and partnering with organisations of persons affected with leprosy and leprosy affected communities to:

Funding

With our deliberately aspirational goals for Zero Transmission, Zero Disability, and Zero Discrimination, all our Member countries have a responsibility to prioritise fundraising collaboration, strategic partnerships and thematic linkages.

By 2030, the TLM Global Fellowship will increase its income to £60m (+50% vs 2023 base) and will fund TLM’s four breakthrough areas to completion.

To achieve this, all of our Member countries will:

17

THE LEPROSY MISSION INTERNATIONAL REPORT OF THE TRUSTEES

FUTURE PLANS (Continued)

STATEMENT OF TRUSTEES’ RESPONSIBILITIES

Company law requires the Trustees to prepare Financial Statements for each financial year, which give a true and fair view of the charity and group’s financial activities during the year and of the charity and group’s financial position at the end of the year. In preparing those Financial Statements giving a true and fair view, the Trustees are required to:

The Trustees also confirm that, so far as each of the Trustees is aware at the time the report is approved:

The Trustees are responsible for keeping proper accounting records which disclose with reasonable accuracy at any time the financial position of the Mission and which enable them to ensure that the Financial Statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the Mission and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

PRINCIPAL ADVISORS

Bankers

Barclays Bank plc 8 George Street Richmond Surrey TW9 1JU

Pension Scheme Actuaries

First Actuarial LLP Network House Basing View Basingstoke Hampshire RG21 4HG

Investment Managers

Rathbone Investment Management Ltd 8 Finsbury Circus London EC2M 7AZ

Auditors

Azets Audit Services Westpoint, Lynchwood Peterborough Cambridgeshire PE2 6FZ

18

THE LEPROSY MISSION INTERNATIONAL REPORT OF THE TRUSTEES

The Report of the Trustees and Financial Statements for the year ended 31 December 2024 and the Prayer Guide for the current year can be obtained from TLM International Office at 80 Windmill Road, Brentford, Middlesex, England TW8 0QH or can be downloaded from our website at www.leprosymission.org.

Following a tender process, the Trustees appointed Azets Audit Services Limited as the company’s auditor for the current year.

This report was approved by the Trustees and signed on their behalf by:

Mr Colin Osborne

Chairperson

20 June 2025

19

THE LEPROSY MISSION INTERNATIONAL

INDEPENDENT AUDITOR'S REPORT

TO THE MEMBERS OF THE LEPROSY MISSION INTERNATIONAL

Opinion

We have audited the financial statements of The Leprosy Mission International (the ‘charity’) and it's subsidiary for the year ended 31 December 2024 which comprise the group statement of financial activities, the group and parent balance sheets, the group statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion, the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the group and parent charity in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the trustees' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charity’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The trustees are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

THE LEPROSY MISSION INTERNATIONAL

INDEPENDENT AUDITOR'S REPORT (CONTINUED) TO THE MEMBERS OF THE LEPROSY MISSION INTERNATIONAL

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the charity and its environment obtained in the course of the audit, we have not identified material misstatements in the directors' report included within the trustees' report.

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

Responsibilities of trustees

As explained more fully in the statement of trustees' responsibilities, the trustees, who are also the directors of the charity for the purpose of company law, are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the trustees are responsible for assessing the charity’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the charitable company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https:// www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

THE LEPROSY MISSION INTERNATIONAL

INDEPENDENT AUDITOR'S REPORT (CONTINUED) TO THE MEMBERS OF THE LEPROSY MISSION INTERNATIONAL

Extent to which the audit was considered capable of detecting irregularities, including fraud

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above and on the Financial Reporting Council’s website, to detect material misstatements in respect of irregularities, including fraud.

We obtain and update our understanding of the entity, its activities, its control environment, and likely future developments, including in relation to the legal and regulatory framework applicable and how the entity is complying with that framework. Based on this understanding, we identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. This includes consideration of the risk of acts by the entity that were contrary to applicable laws and regulations, including fraud.

In response to the risk of irregularities and non-compliance with laws and regulations, including fraud, we designed procedures which included:

Enquiry of management and those charged with governance around actual and potential litigation and claims as well as actual, suspected and alleged fraud; Reviewing minutes of meetings of those charged with governance;

Assessing the extent of compliance with the laws and regulations considered to have a direct material effect on the financial statements or the operations of the entity through enquiry and inspection; Reviewing financial statement disclosures and testing to supporting documentation to assess compliance with applicable laws and regulations;

Performing audit work over the risk of management bias and override of controls, including testing of journal entries and other adjustments for appropriateness, evaluating the business rationale of significant transactions outside the normal course of business and reviewing accounting estimates for indicators of potential bias.

Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

Use of our report

This report is made solely to the charitable company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the charitable company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and the charitable company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

Tracey Richardson BSc (Hons) FCA (Senior Statutory Auditor)

for and on behalf of Azets Audit Services

9 September 2025 .........................

Chartered Accountants Statutory Auditor

Westpoint Lynch Wood Peterborough Cambridgeshire United Kingdom PE2 6FZ

THE LEPROSY MISSION INTERNATIONAL

STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT

FOR THE YEAR ENDED 31 DECEMBER 2024

Current financial year
Unrestricted
funds
2024
Notes
£
Income and endowments from:
Donations
3
118,107
Other trading activities
4
1,719,002
Investments
5
242,231
Other income
6
527,612
Total income
2,606,952
Expenditure on:
Raising funds
7
2,548,371
Charitable activities
8
-
Total expenditure
2,548,371
Net gains/(losses) on investments
12
98,906
Net incoming/(outgoing) resources
157,487
Other recognised gains and losses
Other gains or losses
13
-
Net movement in funds
157,487
Fund balances at 1 January 2024
7,144,233
Fund balances at 31 December 2024
7,301,720		 Restricted
funds
2024
£
9,679,600
-
-
-
9,679,600
(91,771)
9,636,711
9,544,940
(532,611)
(397,951)
121,532
(276,419)
4,720,717
4,444,298		 Total
Total
As restated
2024
2023
£
£
9,797,707
9,957,181
1,719,002
1,787,449
242,231
125,685
527,612
684,069
12,286,552
12,554,384
2,456,600
2,500,854
9,636,711
8,978,266
12,093,311
11,479,120
(433,705)
127,053
(240,464)
1,202,317
121,532
(178,309)
(118,932)
1,024,008
11,864,950
10,840,942
11,746,018
11,864,950

The statement of financial activities includes all gains and losses recognised in the year.

All income and expenditure derive from continuing activities.

The statement of financial activities also complies with the requirements for an income and expenditure account under the Companies Act 2006.

THE LEPROSY MISSION INTERNATIONAL

STATEMENT OF FINANCIAL ACTIVITIES (CONTINUED) INCLUDING INCOME AND EXPENDITURE ACCOUNT

FOR THE YEAR ENDED 31 DECEMBER 2024

Prior financial year

Unrestricted
funds
2023
Notes
£
Income and endowments from:
Donations
3
206,798
Other trading activities
4
1,787,449
Investments
5
125,685
Other income
6
684,069
Total income
2,804,001
Expenditure on:
Raising funds
7
2,465,854
Charitable activities
8
-
Total expenditure
2,465,854
Net gains/(losses) on investments
12
326,150
Net incoming/(outgoing) resources
664,297
Other recognised gains and losses
Other gains or losses
13
-
Net movement in funds
664,297
Fund balances at 1 January 2023
6,479,936
Fund balances at 31 December 2023
7,144,233		 Restricted
funds
2023
£
9,750,383
-
-
-
9,750,383
35,000
8,978,266
9,013,266
(199,097)
538,020
(178,309)
359,711
4,361,006
4,720,717		 Total
2023
£
9,957,181
1,787,449
125,685
684,069
12,554,384
2,500,854
8,978,266
11,479,120
127,053
1,202,317
(178,309)
1,024,008
10,840,942
11,864,950

THE LEPROSY MISSION INTERNATIONAL

BALANCE SHEETS

AS AT 31 DECEMBER 2024

Group Group Charity Charity
2024 2023 2024 2023
Notes £ £ £ £
Fixed assets
Intangible assets 15 - 25,000 - -
Tangible assets 16 935,338 1,169,250 934,492 1,169,250
Investments 17 6,686,727 7,146,726 7,383,906 7,858,566
7,622,065 8,340,976 8,318,398 9,027,816
Current assets
Stocks 19 138,392 148,481 - -
Debtors 20 1,341,527 1,374,867 1,375,337 1,373,587
Cash at bank and in hand 4,313,836 4,338,381 3,379,213 3,378,795
5,793,755 5,861,729 4,754,550 4,752,382
Creditors: amounts falling due within 21
one year (1,288,341) (1,907,686) (945,469) (1,485,179)
Net current assets 4,505,414 3,954,043 3,809,081 3,267,203
Total assets less current liabilities 12,127,479 12,295,019 12,127,479 12,295,019
Creditors: amounts falling due after 22
more than one year (381,461) (430,069) (381,461) (430,069)
Net assets 11,746,018 11,864,950 11,746,018 11,864,950
Income funds
Restricted funds 24 4,444,298 4,720,717 4,444,298 4,720,717
Unrestricted funds
Designated funds 23 1,632,517 1,906,090 1,632,517 1,906,090
General unrestricted funds 5,669,203 5,769,663 5,669,203 5,238,143
11,746,018 11,864,950 11,746,018 11,864,950

As permitted by section 408 of the Companies Act 2006, the charitable company has not presented its own statement of financial activities and related notes. The results of the charitable company (TLMI) before consolidation show a total income of £10,569,498 (2023 - £10,756,832) and expenditure of £10,361,596 (2023 - - £9,730,042) resulting in a surplus before realised and unrealised investment gains of £207,902 (2023 £1,026,790). The result was a deficit of £118,932 (2023 - £721,428) after recognising the investment gain for the year.

The financial statements were approved by the board of directors and authorised for issue on 20 June 2025 and are signed on its behalf by:

Mr C Osborne Mr G H Brown Chair of Trustees Treasurer Company Registration No. 03591514

THE LEPROSY MISSION INTERNATIONAL

STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 31 DECEMBER 2024

Notes
Cash flows from operating activities
Cash (absorbed by)/generated from
operations
28
Investing activities
Purchase of tangible fixed assets
Proceeds from disposal of tangible fixed
assets
Investment income received
Net cash generated from investing
activities
Financing activities
Change in fair value of derivatives
Net cash (used in)/generated from
financing activities
Net (decrease)/increase in cash and cash
equivalents
Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of year		 2024
£
£
(243,026)
(2,218)
100,000
242,231
340,013
(121,532)
(121,532)
(24,545)
4,338,381
4,313,836		 2023
£
£
960,248
(11,366)
-
125,685
114,319
178,309
178,309
1,252,876
3,085,505
4,338,381		 2023
£
£
960,248
(11,366)
-
125,685
114,319
178,309
178,309
1,252,876
3,085,505
4,338,381
1,252,876
3,085,505
4,338,381

THE LEPROSY MISSION INTERNATIONAL

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024

1 Accounting policies

Charity information

The Leprosy Mission International is a private company limited by guarantee incorporated in England and Wales. The registered office is 80 Windmill Road, Brentford, Middlesex, TW8 0QH, United Kingdom.

1.1 Accounting convention

The financial statements have been prepared in accordance with the charity's governing document, the Companies Act 2006, FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the Charities SORP "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)" (effective 1 January 2019). The charity is a Public Benefit Entity as defined by FRS 102.

These financial statements consolidate the results of the charitable company and its wholly-owned subsidiary TLM Trading Limited on a line by line basis. Transactions and balances between the charitable company and its subsidiary have been eliminated from the consolidated financial statements. Balances between the two companies are disclosed in the notes of the charitable company's balance sheet. A separate statement of financial activities, or income and expenditure account, for the charitable company itself is not presented because the charitable company has taken advantage of the exemptions afforded by section 408 of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the charity. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2 Going concern

At the time of approving the financial statements, the trustees have a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future. Thus the trustees continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3 Charitable funds

General unrestricted funds include movements on general funds. They are available for use at the discretion of the Trustees for the furtherance of the Mission's work.

Designated funds are amounts which have been put aside at the discretion of the Trustees which represent the net book value of fixed assets in use by the Mission and the investment value of TLM Trading Limited.

Restricted funds are subject to specific conditions by donors as to how they may be used. The purposes and uses of the restricted funds are set out in the notes to the financial statements.

1.4 Income

Income from Supporting Countries and Support Groups, investment income and interest on deposits are dealt with on a receivable basis. All income is included in the Statement of Financial Activities (SOFA) when the charity is legally entitled to the income, the amount can be quantified with reasonable accuracy and receipt is probable.

Revenue from TLM Trading Limited comprises income from the sale of goods through its catalogue and online website. Where applicable, income is realised net of value added tax.

THE LEPROSY MISSION INTERNATIONAL

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

1 Accounting policies

(Continued)

1.5 Expenditure

All expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all costs relating to the category. Where costs cannot be directly attributed to particular headings, they have been allocated on the basis of time spent.

Costs of generating funds : Includes costs associated with activities which are directly involved in generating income for the Mission.

Charitable activities : Includes payment of grants to programmes and apportioned support costs. Grants are paid in accordance with the budget approved by the Board.

Governance costs : Includes costs associated with the governance arrangements of the Mission which includes audit fees and expenses relating to governance structure.

Support costs : Includes costs associated with the day to day management of the Mission. These costs can not be directly associated to a particular activity of the charity and accordingly are apportioned on the basis of time spent.

1.6 Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

TLM Trading Limited website 3 years straight line

1.7 Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses. The Mission capitalises assets above the value of £500.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Freehold buildings 2% per annum straight line
Leasehold buildings 2% per annum straight line
Building improvements 10% per annum straight line
Equipment 20% per annum straight line
Computers 33% per annum straight line

Freehold and leasehold land is not depreciated.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the statement of financial activities.

THE LEPROSY MISSION INTERNATIONAL

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

1 Accounting policies

(Continued)

1.8 Fixed asset investments

Fixed asset investments are included in the Financial Statements at market value and associated realised and unrealised gains and losses are showing the Statement of Financial Activities.

Unlisted investments, which comprise the investment in TLM Trading Limited, are stated at fair value which is calculated as the net assets of the company.

All income from investments is shown on an accrued basis and used for the furtherance of the Mission's work.

1.9 Impairment of fixed assets

At each reporting end date, the charity reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).

1.10 Stocks

Stocks consist of merchandise for resale by TLM Trading Limited and are valued at the lower of cost and net realisable value. Cost is determined principally on the first in first out basis.

Net realisable value is the estimated selling price less all estimated costs of completion and costs to be incurred in marketing, selling and distribution.

1.11 Cash and cash equivalents

Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.12 Financial instruments

The charity has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the charity's balance sheet when the charity becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

THE LEPROSY MISSION INTERNATIONAL

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

1 Accounting policies

(Continued)

Basic financial liabilities

Basic financial liabilities, including creditors and bank loans are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of operations from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Derecognition of financial liabilities

Financial liabilities are derecognised when the charity’s contractual obligations expire or are discharged or cancelled.

1.13 Derivatives

The charity has entered into foreign currency forward exchange contracts with financial institutions. Fair value is derived as the movement in the forward exchange rate that has been achieved between the dates the contract was entered into and the balance sheet date.

1.14 Taxation

The Leprosy Mission International has a wholly owned trading subsidiary, TLM Trading Limited which is a registered company in England and Wales. Part of the profit is donated by Gift Aid to The Leprosy Mission International.

The Leprosy Mission International is a registered charity and is thus exempt from tax on income and gains falling within chapter 3 of part II of the Corporation Tax Act 2010 or s256 of the Taxation of Chargeable Gains Act 1992 to the extent that these are applied to its charitable objects. No tax charges have arisen in the charity.

1.15 Employee benefits

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the charity is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.16 Retirement benefits

The Mission operates a non-contributory defined contribution pension scheme with AVIVA. Previously it participated in a multi-employer defined benefit scheme providing benefits based upon career averaged revalued earnings, which was closed on 31 March 2013 for all employees. In accordance with FRS102, deficit funding for the pension scheme in which the Mission participates is accrued at current value in creditors falling due after more than one year.

1.17 Leases

Rentals payable under operating leases, including any lease incentives received, are charged as an expense on a straight line basis over the term of the relevant lease.

THE LEPROSY MISSION INTERNATIONAL

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

1 Accounting policies

(Continued)

1.18 Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in the Statement of Financial Activities.

1.19 Grant making

Grants are given annually to programmes, which fit the vision and strategy approved by the Board. All programmes are required to prepare annual plans and budgets. Grants are paid in accordance with the approved annual plan/budgets.

2 Critical accounting estimates and judgements

In the application of the charity’s accounting policies, the trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Unrestricted
Restricted
Total
Unrestricted
Restricted
Total		 funds
funds
funds
funds As restated		 2024
2024
2024
2023
2023
2023		 £
£
£
£
£
£		 Remittances from TLM Supporting Member Countries
118,107
8,984,799
9,102,906
206,798
9,070,220
9,277,018		 Remittances from Other Donor Organisations
-
694,801
694,801
-
680,163
680,163		 118,107
9,679,600
9,797,707
206,798
9,750,383
9,957,181		 Remittances represent funds received by TLM Fellowship Member countries and other donor organisations. Supporting Countries’ own costs of fundraising and administration have been deducted from their income and included in their own accounts. The Supporting Countries and other donor organisations remitted funds directly to TLM programmes and through The Leprosy Mission International (TLMI). All income received by The Leprosy Mission International during the year is shown in the Statement of Financial activities. Unspent restricted fund balances are carried forward to subsequent years. Comparison between years is affected due to actual exchange rates applied in respective periods.

(Continued) Total received in TLMI 2023 £ 169,986 18,393 19,959 13,840 76,490 169,749 4,610,217 145,088 865,561 773,082 422,927 - 363,664 36,689 9,487 1,581,886 9,277,018 23,542 - - 51,105 74,647
Total
Sent directly		 donations
to		 programmes 2023
2023		 £
£		 1,325,018
(1,155,032)		 18,393
-		 164,451
(144,492)		 13,840
-		 76,490
-		 225,706
(55,957)		 6,459,989
(1,849,772)		 145,088
-		 1,618,449
(752,888)		 2,043,725
(1,270,643)		 422,927
-		 5,686
(5,686)		 363,664
-		 36,689
-		 881,908
(872,421)		 1,581,886
-		 15,383,909
(6,106,891)		 23,542
-		 391,083
(391,083)		 -
-		 51,105
-		 465,730
(391,083)
Total received in TLMI 2024 £ 200,896 13,115 13,505 9,221 75,890 189,535 4,401,891 143,345 1,094,257 714,034 514,005 - - 34,093 11,585 1,687,534 9,102,906 - - 25,332 41 25,373
Total
Sent directly		 donations
to		 programmes 2024
2024		 £
£		 1,426,728
(1,225,832)		 13,115
-		 159,313
(145,808)		 9,221
-		 75,890
-		 189,535
-		 5,776,783
(1,374,892)		 143,345
-		 1,464,566
(370,309)		 2,207,180
(1,493,146)		 514,005
-		 3,611
(3,611)		 -
-		 34,093
-		 576,037
(564,452)		 1,687,534
-		 14,280,956
(5,178,050)		 -
-		 65,582
(65,582)		 25,332
-		 41
-		 90,955
(65,582)
Donations Remittances from TLM Supporting Member Countries: Australia Belgium Denmark Finland France Germany Great Britain Hungary Netherlands New Zealand Northern Ireland Norway Scotland South Korea Sweden Switzerland Remittances from Other Donor Organisations: AIFO ALM: AIM / ASHA Banglabari (Belgium) Betty Isabel Balmain Estate Other Donor Organisations carried forward to next page

(Continued) 74,647 34,183 179,848 - - 100,995 22,549 - 103,275 - - - - 49,808 84,126 - 15,709 - - 12,863 - 2,160 - 680,163 9,957,181
(391,083) - - (554,049) - - - (55,646) - - - - (32,026) (93,104) - (74,275) - (14,738) - - (15,000) (353,592) - (1,583,513) (7,690,404)
465,730 34,183 179,848 554,049 - 100,995 22,549 55,646 103,275 - - - 32,026 142,912 84,126 74,275 15,709 14,738 - 12,863 15,000 355,752 - 2,263,676 17,647,585
25,373 33,691 182,834 - - 28,853 - - 144,231 - - 115,383 - 52,787 38,523 - - - - 12,859 30,000 - 30,267 694,801 9,797,707
(65,582) - - (538,349) (6,172) - - - - (31,476) (59,814) - - (69,477) - (14,768) (22,956) - (57,669) - - (330,588) - (1,196,851) (6,374,901)
90,955 33,691 182,834 538,349 6,172 28,853 - - 144,231 31,476 59,814 115,383 - 122,264 38,523 14,768 22,956 - 57,669 12,859 30,000 330,588 30,267 1,891,652 16,172,608
Donations Other Donor Organisations brought forward from prior page CoWater Intl Danish Church Aid Effect Hope Foundation Raoul Follereau (FRF) International Committee of the Red Cross Italy JSI - USA Leprosy Research Initiative (LRI) London School of Hygiene Medicines Dev for Global Health Mine Advisory Group Netherlands Leprosy Relief (NLR) Norec (Norwegian Agency for Exch Co) Old Dart Foundation Probitas Spain Sasakawa Health Foundation Solidarite Protestante The Mission to end Leprosy (TLM Ire) TLM Spain Tearfund University of Birmingham (NIHR) ZOA
3

FOR THE YEAR ENDED 31 DECEMBER 2024 3
Donations
(Continued)		 TLM Trading Limited received £626,977 (2023 - £542,248) as general donations and Gift for Life donations from its customers. In recognition of the use of donor database of TLM Supporting Countries, the donations were given to the respective TLM Supporting Countries. These donations are accounted for in the accounts of the respective TLM Supporting country. Total
Total		 2024
2023		 £
£		 TLM Great Britain
583,865
459,394		 TLM Northern Ireland
43,112
31,118		 TLM Scotland
-
51,736		 626,977
542,248

THE LEPROSY MISSION INTERNATIONAL

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

4 Other trading activities

TLM Trading Limited (company number 03045864) an incorporated UK company, is a wholly owned subsidiary. A summary of its trading results is shown below. Audited accounts have been filed with the Registrar of Companies.

Turnover
Bank interest and royalties receivable
Other operating income
Cost of sales
Distribution costs
Administrative expenses *
Operating profit before taxation and defined benefit pension scheme
Gift Aid donation to TLM International
Profit / (loss) for the financial year
The aggregate of the assets, liabilities and funds was:
Total assets
Total liabilities
Funds		 Total
2024
£
1,446,803
15,526
291,673
1,754,002
(521,204)
(727,554)
(517,958)
(12,714)
(1,947)
(14,661)
1,142,030
(444,851)
697,179		 Total
2023
£
1,584,859
14,165
223,425
1,822,449
(594,704)
(725,073)
(483,492)
19,180
-
19,180
1,134,347
(422,507)
711,840

** Administrative expenses include a fee of £14,400 (2023 - £14,400) for accounting services by the parent charity which is eliminated upon consolidation.

5 Investments

**Unrestricted ** Unrestricted
funds funds
2024 2023
£ £
Income from listed investments 133,649 120,607
Interest receivable 108,582 5,078
242,231 125,685

THE LEPROSY MISSION INTERNATIONAL

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

6 Other income

Unrestricted Unrestricted
funds
funds
2024
2023
£
£
393,082
388,619
134,530
295,450
527,612
684,069
Total
Total
2024
2023
£
£
689,884
711,985
1,766,716
1,788,869
2,456,600
2,500,854		 Unrestricted Unrestricted
funds
funds
2024
2023
£
£
393,082
388,619
134,530
295,450
527,612
684,069
Total
Total
2024
2023
£
£
689,884
711,985
1,766,716
1,788,869
2,456,600
2,500,854
Refund from Special Pension Account
Other income
Raising funds
Expenditure on raising funds
TLM Trading Limited
684,069
Total
2023
£
711,985
1,788,869
2,500,854

7 Raising funds

As restated Total 2023 £ 7,419,382 1,558,884 8,978,266 As restated Total 2023 £ 7,419,382 1,558,884 8,978,266
Research
Total		 2024
2024		 £
£		 402,313
7,918,268		 87,641
1,718,443		 489,954
9,636,711		 Education
Research		 £
£		 778,959
371,279		 166,801
79,503		 945,760
450,782
Disability Public
care &
Community		 Health
Hospitals
prevention
Development
Education		 2024
2024
2024
2024
2024		 £
£
£
£
£		 1,475,152
1,309,492
2,161,452
1,696,030
844,071		 321,349
285,262
470,853
369,465
183,873		 1,796,501
1,594,754
2,632,305
2,065,495
1,027,944		 Nepal
Disability		 Trauma
Public
care &
Community		 Centre
Health
Hospitals
prevention
Development		 £
£
£
£
£		 174,393
1,361,358
1,208,478
1,959,717
1,565,198		 -
291,511
258,775
427,134
335,160		 174,393
1,652,869
1,467,253
2,386,851
1,900,358
Nepal Trauma Centre 2024 £ 29,758 - 29,758
Charitable activities Programme costs Share of support costs (see note ) For the year ended 31 December 2023 Programme costs Share of support costs (see note )
8

THE LEPROSY MISSION INTERNATIONAL

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

9 Programme costs

Most of the Mission’s programmes are carried out through grants to associated local organisations, which provide medical care and sustainable benefits for individuals and communities affected by leprosy. The programmes listed below are the major grants given during the year including the 50 largest programmes, representing more than 75% of total programme expenditure. These amounts include the associated support costs.

Country/Programme
Bangladesh
Advocacy for Empowerment
Chittagong Hill Tracts
Chittagong People Led Development
Country Office/Project Management
Gaibandha-Jaypurhat LCP
Nilphamari (DBLM)
Empower Disadvantaged Communities
LepFire/PEP++/SCORE/To B or Not To B
CBR/Hagar/Proyash/LCP/SHGs
Emergency Flood Relief Programme
Chad
GRACE
Leprosy Programmes
Social Reintegration
D R Congo
Kasai Leprosy Projects
GIPAL/ Inclusion of Children, Mapping My Village
South Kivu, Kongo Central
Sankuru & Septic Surgery
Ethiopia
Dare to Dream / Income Generating /Education
India
Bankura Leprosy Hospital
Bankura VTC
Brighter Future Development
Community - Cap Builing, Interrupt Transmission,
Replicable Model
Champa Hospital
Champa VTC
Chandkhuri Leprosy Hospital
College on Wheels
Cocreating Inclusive Development (CID)
Faizabad Hospital and VTC
Kolkata Leprosy Hospital
Zero Leprosy Transmission Delhi
Carried forward		 Main Activity
Community Programme
Leprosy Control
Community Programme
Co-ordination
Leprosy Control Prog (LCP)
Hosp/Rehab/Research/Train
Community Programme
Research
Community Programme
Relief
Rehabilitation
Community Prog / Leprosy
Control
Mental Health Programme
Leprosy Control/Tech Support
Inclusion/Rehab/Leprosy Control
Leprosy Control
Leprosy/TB Control
Rehabilitation/Training
Hospital Prog/Training
Vocational Training
Community Programme
Community Programme
Hospital
Vocational Training
Hospital Programme
Rehabilitation
Hospital and Vocational Training
Hospital Programme
Hospital Programme		 2024
£
347,159
115,994
25,179
214,112
40,659
423,348
42,129
351,301
181,262
12,711
108,421
57,077
9,211
116,467
252,236
47,233
3,159
139,806
-
87,535
113,674
74,919
187,231
60,350
140,603
66,486
-
109,501
66,575
44,836
3,439,174		 2023
£
309,387
122,706
90,241
191,752
17,163
281,883
48,566
286,435
145,875
-
109,332
61,057
4,364
116,814
174,096
88,174
39,903
40,302
23,498
55,941
-
56,775
66,005
51,348
67,938
63,037
6,251
60,521
103,792
9,168
2,692,324

THE LEPROSY MISSION INTERNATIONAL

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

Programme costs
Brought forward
Plantar Ulcer Trial / Heal after MDT study
Research/Study/Trials
Medical Care in Naini, Delhi
Hospital Programme
Mental Health in Bihar
Mental Health Programme
Miraj Leprosy Hospital & Research
Hospital Programme/Research
Muzzaffarpur Leprosy Hospital
Hospital Programme
Naini Hospital
Hospital Programme
Nashik VTC
Vocational Training
Purulia Leprosy Hospital
Hospital Programme
Rehabilitation (nationwide) / CUFA
Rehabilitation
Salur Leprosy Hospital
Hospital Programme
Advocacy & Communication / Mass Media Centre
Advocacy/Communication
Vadathorasalur, Vizianagaram VTC
Vocational Training
India Office Supervision
Tech.Support/Supervision
Indonesia
PEPCOM / Leprosy Villages
Leprosy Control/Community
Mozambique
Mission Zero / Multiplying Inclusion
Leprosy Control/Empowerment
Myanmar
Emergency Support
Relief/Rehabilitation
LIGHT - Inclusion, Accessibility, Resilience
Community Programme
Myanmar Country Office
Co-ordination
GRACE/RLII
Community/Empowerment/
Rehab
SLICE / Transformation & Renewal E.Shan / PRIDE
Relief/Rehabilitation
Staff exchange Norec
Training
Nepal
Anandaban Hospital
Hospital Programme
Anandaban & Leprosy Research Initiatives
Research/Training
Anandaban Trauma Centre
Hospital Programme
Anandaban Landslide Emergency Response
Relief
Central Region - Nepal
Technical Support
Impact/Contact Tracing/Strengthening
Community Programme
Nepal Country Office
Co-ordination
Dignity First
Community Programme
International Nepal Fellowship
Community Programme
Satellite Clinic Birathnagar
Community Programme
SEED / SILP
Empower/Livelihood
Niger
Danja/Niamey & Tillabery
Leprosy Control/Rehab
Emergency Response
Relief/Rehabilitation
Carried forward		 (Continued)
3,439,174
2,692,324
19,835
54,135
90,379
97,303
55,802
31,192
117,612
137,960
302,688
-
93,389
34,453
21,401
76,157
263,264
235,604
72,522
69,683
43,597
550,427
80,356
83,103
30,126
26,839
140,466
191,644
949
1,839
116,903
78,358
30,267
104,599
353,652
117,113
87,111
103,473
437,579
532,569
52,855
35,816
59,215
55,038
584,721
525,881
258,089
170,423
38,474
174,393
100,000
-
98,357
30,928
19,877
24,089
128,376
111,861
198,216
136,468
-
19,393
-
32,306
-
37,353
536,867
543,095
-
20,623
7,872,119
7,136,442		 (Continued)
3,439,174
2,692,324
19,835
54,135
90,379
97,303
55,802
31,192
117,612
137,960
302,688
-
93,389
34,453
21,401
76,157
263,264
235,604
72,522
69,683
43,597
550,427
80,356
83,103
30,126
26,839
140,466
191,644
949
1,839
116,903
78,358
30,267
104,599
353,652
117,113
87,111
103,473
437,579
532,569
52,855
35,816
59,215
55,038
584,721
525,881
258,089
170,423
38,474
174,393
100,000
-
98,357
30,928
19,877
24,089
128,376
111,861
198,216
136,468
-
19,393
-
32,306
-
37,353
536,867
543,095
-
20,623
7,872,119
7,136,442
7,136,442

9 Programme costs

THE LEPROSY MISSION INTERNATIONAL

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

9
Programme costs
Brought forward
Nigeria
Integrated Leprosy & LF Case Finding / Pro-skin
Leprosy Control
Kwara/Kebbi/Kogi/Niger/ Sokoto States
Leprosy Control/Rehab
Orthopaedic / Ekpene Obom Limb Workshop / Esther
Davies Ward
Rehabilitation
Nigeria Co-ordination, Harnessing Resources
Supervision
Ready for PEP, RIGHT 1 & CapaBLe
Research
Papua New Guinea
Empowerment/SED/ Leprosy Control Partnership
Rehabilitation
Sri Lanka
Case Finding, Detection, Integration, Capacity Building
Community Programme
Sudan
Omdurman & Khartoum
Tech.Support/Supervision
Tanzania
Hombolo Hospital Programme & Housing
Leprosy Control/Rehabilitation
Timor Leste
National Programme
Leprosy Control
Other grants sent to projects in above countries
Global support office costs		 (Continued)
7,872,119
7,136,442
50,898
47,268
9,362
10,557
-
83,565
114,885
103,959
21,003
-
104,347
146,514
476,681
291,554
9,008
25,945
-
14,091
-
3,244
233,933
307,563
744,475
807,564
9,636,711
8,978,266		 (Continued)
7,872,119
7,136,442
50,898
47,268
9,362
10,557
-
83,565
114,885
103,959
21,003
-
104,347
146,514
476,681
291,554
9,008
25,945
-
14,091
-
3,244
233,933
307,563
744,475
807,564
9,636,711
8,978,266
8,978,266

10 Trustees

The Trustees received no remuneration or retirement benefits for their services. Ten Trustees (2023 - eleven) were reimbursed for travel expenses and out of pocket expenses during the year, amounting to a total of £13,492 (2023 - £14,921).

The Leprosy Mission International has purchased indemnity insurance that provides cover:

11 Employees

The average monthly number of employees during the year was:

year was:
2024 2023 2024 2023
Group Group Charity Charity
Number Number Number Number
25 30 17 23

THE LEPROSY MISSION INTERNATIONAL

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

11
Employees
Employment costs
Wages and salaries
Social security costs
Other pension costs		 Group
2024
£
1,427,809
137,078
183,934
1,748,821		 Group
2023
£
1,316,947
129,372
175,172
1,621,491		 (Continued)
Charity
Charity
2024
2023
£
£
1,130,454
1,036,678
104,807
101,560
148,254
142,795
1,383,515
1,281,033		 (Continued)
Charity
Charity
2024
2023
£
£
1,130,454
1,036,678
104,807
101,560
148,254
142,795
1,383,515
1,281,033
1,281,033

Staff costs include the emoluments of cross-cultural staff working on TLM supported programmes and the allocation of these costs is shown in the expenditure notes.

The Mission operates holiday entitlement of 28 working days per annum to its full time staff and part time staff's entitlement is pro rata'd accordingly to its UK employees. The period for calculating annual leave is from 1 January to 31 December and non-cumulative. The accrued holiday entitlement is immaterial for FRS102 disclosure purposes.

The number of employees whose annual remuneration was more than £60,000 is as follows:

£60,001 - £70,000
£70,001 - £80,000
£100,001 - £110,000
12
Net gains/(losses) on investments
Unrestricted
Restricted
funds
funds
2024
2024
£
£
Revaluation of
investments
98,906
(532,611)
13
Other gains or losses
Foreign exchange gains		 Total Unrestricted
funds
2024
2023
£
£
(433,705)
326,150		 2024
2023
Number
Number
4
4
1
1
1
1
Restricted
Total
funds
2023
2023
£
£
(199,097)
127,053
Restricted
Restricted
funds
funds
2024
2023
£
£
(121,532)
178,309		 2023
Number
4
1
1
Total
2023
£
127,053

THE LEPROSY MISSION INTERNATIONAL

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

14 Taxation

The charity is exempt from tax on income and gains falling within section 505 of the Taxes Act 1988 or section 252 of the Taxation of Chargeable Gains Act 1992 to the extent that these are applied to its charitable objects.

15 Intangible fixed assets Group

Intangible fixed assets
Group
TLM Trading Limited
website
£
Cost
At 1 January 2024 and 31 December 2024 75,000
Amortisation and impairment
At 1 January 2024 50,000
Amortisation charged for the year 25,000
At 31 December 2024 75,000
Carrying amount
At 31 December 2024 -
At 31 December 2023 25,000

THE LEPROSY MISSION INTERNATIONAL

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

16
Tangible fixed assets
Group
Freehold land
and buildings
£
Cost
At 1 January 2024
1,104,939
Additions
-
Disposals
-
At 31 December 2024
1,104,939
Depreciation and impairment
At 1 January 2024
511,021
Depreciation charged in the year
14,738
Eliminated in respect of disposals
-
At 31 December 2024
525,759
Carrying amount
At 31 December 2024
579,180
At 31 December 2023
593,919
Charity
Freehold land
and buildings
£
Cost
At 1 January 2024
1,104,939
Additions
-
Disposals
-
At 31 December 2024
1,104,939
Depreciation and impairment
At 1 January 2024
511,021
Depreciation charged in the year
14,738
Eliminated in respect of disposals
-
At 31 December 2024
525,759
Carrying amount
At 31 December 2024
579,180
At 31 December 2023
593,919		 Leasehold
buildings
Building
improvement
Equipment,
computers &
website
£
£
£
190,000
1,164,809
224,045
-
-
2,218
(190,000)
-
(30,227)
-
1,164,809
196,036
90,000
697,702
215,820
-
116,484
4,908
(90,000)
-
(30,227)
-
814,186
190,501
-
350,623
5,535
100,000
467,107
8,224
Leasehold
buildings
Building
improvement
Equipment,
computers &
website
£
£
£
190,000
1,164,809
160,328
-
-
1,348
(190,000)
-
-
-
1,164,809
161,676
90,000
697,702
152,103
-
116,484
4,884
(90,000)
-
-
-
814,186
156,987
-
350,623
4,689
100,000
467,107
8,224		 Total
£
2,683,793
2,218
(220,227)
2,465,784
1,514,543
136,130
(120,227)
1,530,446
935,338
1,169,250
Total
£
2,620,076
1,348
(190,000)
2,431,424
1,450,826
136,106
(90,000)
1,496,932
934,492
1,169,250

THE LEPROSY MISSION INTERNATIONAL

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

16 Tangible fixed assets

(Continued)

Property

The Mission is the beneficial user of one of the properties, Flat 9 The Sackville, Bexhill on Sea, which is registered in the name of The Leprosy Mission Corporation. This property is provided for the accommodation of retired staff and for Supporting Member Countries.

The Mission is the registered owner of a property, 82 Victoria Road, Harborne, which is provided for the accommodation of retired staff and for Supporting Member Countries.

Included within freehold land and buildings is a proportion of the property at 80 Windmill Road, Brentford that is rented to a third party. Due to the unique nature of the building it is not possible to obtain a reliable valuation and therefore this proportion has not been reclassified as an investment property.

The leasehold property was held on behalf of one Supporting Member Country, this was sold during the year.

17 Fixed asset investments Group

Listed
investments
£
Cost or valuation
At 1 January 2024
7,064,912
Additions
715,396
Valuation changes
155,626
Disposals
(1,432,371)
At 31 December 2024
6,503,563
Carrying amount
At 31 December 2024
6,503,563
At 31 December 2023
7,064,912
Fixed asset investments
Charity
Listed
investments
£
Cost or valuation
At 1 January 2024
7,064,912
Additions
715,396
Valuation changes
155,626
Disposals
(1,432,371)
At 31 December 2024
6,503,563
Impairment losses
-
Disposals
-
Carrying amount
At 31 December 2024
6,503,563
At 31 December 2023
7,064,912		 Cash in
portfolio
Investment in
subsidiary
Total
£
81,814
-
7,146,726
101,350
-
816,746
-
-
155,626
-
-
(1,432,371)
183,164
-
6,686,727
183,164
-
6,686,727
81,814
-
7,146,726
Cash in
portfolio
Investment in
subsidiary
Total
£
81,814
711,840
7,858,566
101,350
-
816,746
-
(14,661)
140,965
-
-
(1,432,371)
183,164
697,179
7,383,906
-
-
-
-
-
-
183,164
697,179
7,383,906
81,814
711,840
7,858,566

THE LEPROSY MISSION INTERNATIONAL

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

18 Financial instruments

Financial instruments
2024 2023
£ £
Carrying amount of financial liabilities
Measured at fair value through profit or loss
- Other financial liabilities 62,182 183,713

The Leprosy Mission International places deliverable foreign exchange forward contracts to manage its grant payment exposure to foreign currency exchange risks.

At 31 December 2024 The Leprosy Mission International has £1,624,141 (2023 - £3,484,501) of foreign currency forward contracts in place. The unrealised loss on these forward contracts was £62,182 (2023 - £183,713). The fair value of these foreign currency forward contracts is included in restricted funds.

19 Stocks

19
Stocks
Goods for resale
20
Debtors
Amounts falling due within one year:
Trade debtors
Corporation tax recoverable
Amounts owed by subsidiary undertakings
Other debtors
Prepayments and accrued income		 Group
2024
£
138,392
Group
2024
£
41,187
21,283
-
769,252
509,805
1,341,527		 Group
2023
£
148,481
Group
2023
£
1,154
28,630
-
1,011,800
333,283
1,374,867		 Charity
2024
£
138,392
Charity
2024
£
-
21,283
101,979
769,252
482,822
1,375,336		 Charity
2023
£
148,481
Charity
2023
£
-
28,630
30
1,011,770
333,157
1,373,587

THE LEPROSY MISSION INTERNATIONAL

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

21
Creditors: amounts falling due within one year
Notes
Other taxation and social
security
Derivative financial instruments
Deferred income
Trade creditors
Other creditors
Accruals		 Group
2024
£
73,433
62,182
7,804
259,019
243,320
642,583
1,288,341		 Group
2023
£
66,220
183,713
175,469
228,552
424,413
829,319
1,907,686		 Charity
2024
£
25,631
62,182
7,804
60,639
163,627
625,586
945,469		 Charity
2023
£
21,186
183,713
175,469
-
309,152
795,659
1,485,179

The Mission has an overdraft facility with Barclays Bank plc of £1,000,000, which is secured against the office building and against its investment portfolio, which is managed by Rathbones Investment Management Limited.

22
Creditors: amounts falling due after more than one year
Group
2024
£
Chad staff medical provision
26,814
Longterm severance pay
230,511
Resettlement fund
72,061
Superannuation fund
52,075
381,461		 Group
2023
£
20,684
257,519
91,755
60,111
430,069		 Charity
2024
£
26,814
230,511
72,061
52,075
381,461		 Charity
2023
£
20,684
257,519
91,755
60,111
430,069

Chad staff medical provision fund is held with TLMI for staff medical provision which is part of employment benefit. Other implementing countries hold this benefit provision in country.

The resettlement fund and the superannuation fund are accrued benefits to the personnel who are working in the field which are payable at the time they leave the Mission. The total liability does not exceed the balance held at the closing date and is represented by cash held on deposit.

THE LEPROSY MISSION INTERNATIONAL

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

23 Designated funds

The income funds of the charity include the following designated funds which have been set aside out of unrestricted funds by the trustees for specific purposes:

Balance at Consolidated Balance at Consolidated Balance at
1 January movements 1 January movements 31 December
2023 2024 2024
£ £ £ £ £
Fixed assets used by the Mission 1,256,205 (161,955) 1,094,250 (158,912) 935,338
Fixed assets held on behalf of
Supporting Countries 121,600 (21,600) 100,000 (100,000) -
TLM Trading Limited 692,660 19,180 711,840 (14,661) 697,179
2,070,465 (164,375) 1,906,090 (273,573) 1,632,517

Fixed assets used by the Mission / fixed assets held on behalf of Supporting Countries

At 31 December 2024, fixed assets used by the Mission and held on behalf of Supporting Countries have been shown at net book value as at this date.

TLM Trading Limited

The fund represents the net asset value of the charity's subsidiary company, TLM Trading Limited at 31 December 2024.

Restricted funds The income funds of the charity include restricted funds comprising the following unexpended balances of donations and grants held on trust for specific purposes: Movement in funds
Movement in funds		 Balance at
Incoming
Resources
Revaluations,
Balance at
Incoming
Resources
Revaluations,
Balance at		 1 January 2023
resources
expended
gains and
1 January 2024
resources
expended
gains and
31 December		 losses
losses
2024		 £
£
£
£
£
£
£
£
£		 Nepal Trauma Centre
214,083
-
(174,393)
-
39,690
-
(39,690)
-
-		 Public Health
49,771
1,473,466
(1,501,855)
-
21,382
1,642,091
(1,657,283)
-
6,190		 Hospitals
211,429
1,291,767
(1,333,197)
-
169,999
1,809,289
(1,471,170)
-
508,118		 Disability Care and Prevention
-
3,041,740
(3,008,143)
-
33,597
3,047,427
(3,081,024)
-
-		 Community Development
29,121
1,912,896
(1,726,731)
-
215,286
1,871,043
(1,905,434)
-
180,895		 Education
-
986,113
(859,350)
-
126,763
854,640
(906,036)
-
75,367		 Research / Laboratory
789,234
1,044,401
(409,597)
-
1,424,038
455,110
(484,303)
-
1,394,845		 Special Pension Account
3,072,772
-
-
(199,097)
2,873,675
-
-
(532,611)
2,341,064		 Derivatives Fair Value
(5,404)
-
-
(178,309)
(183,713)
-
-
121,532
(62,181)		 4,361,006
9,750,383
(9,013,266)
(377,406)
4,720,717
9,679,600
(9,544,940)
(411,079)
4,444,298		 Restricted funds Restricted funds are amounts which have been given to the Mission for specific purposes and are held in cash deposits. Nepal Trauma Centre and Laboratory Construction The funds raised in respect of the Trauma Centre and the Laboratory construction in Nepal, which had not been utilised at 31 December 2024. Special Pensions Account In 2012 the Mission agreed with the Pension Fund Trustees a payment of £1,000,000 into an escrow account as part of the continued funding conditions of the Scheme. Depending upon the outcome of subsequent actuarial valuations, monies would remain in escrow or be paid into the Scheme or returned to the charity. The Leprosy Mission International and the Trustees agreed by Deed dated 30 June 2015 that the assets held in the escrow account would transfer to a Special Pension Account to be held by The Leprosy Mission International under similar terms to the escrow account.
24

Restricted funds
(Continued)		 Fair Value of Derivatives The Mission has entered into foreign currency forward exchange contracts with financial institutions. FRS102 requires an entity to value derivatives at fair value. The purpose of these forward exchange contracts is to hedge grant payments in foreign currencies to programme implementing countries, which reduces the risk of uncertainty. Fair value is derived as the movement in the forward exchange rate that has been achieved between the date the contract was entered into and the balance sheet date. The fund represents the fair value of those contracts at 31 December 2024. Analysis of net assets between funds Unrestricted
Designated
Restricted
Total Unrestricted
Designated
Restricted
Total		 funds
funds
funds
funds
funds
funds		 2024
2024
2024
2024
2023
2023
2023
2023		 £
£
£
£
£
£
£
£		 Fund balances at 31 December 2024 are represented by: Intangible fixed assets
-
-
-
-
-
25,000
-
25,000		 Tangible assets
-
935,338
-
935,338
-
1,169,250
-
1,169,250		 Investments
4,345,663
-
2,341,064
6,686,727
4,273,051
-
2,873,675
7,146,726		 Current assets/(liabilities)
1,705,001
697,179
2,103,234
4,505,414
1,395,161
711,840
1,847,042
3,954,043		 Long term liabilities
(381,461)
-
-
(381,461)
(430,069)
-
-
(430,069)		 5,669,203
1,632,517
4,444,298
11,746,018
5,238,143
1,906,090
4,720,717
11,864,950
24 25

THE LEPROSY MISSION INTERNATIONAL

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

26 Retirement benefit schemes

The Mission operated a non-contributory multi-employer pension scheme providing benefits based upon career averaged re-valued earnings. The career averaged re-valued earnings scheme was closed to new members effective from 12 November 2007 and with effect from 31 March 2013 the scheme was closed to new accruals. The Mission's pension contributions are determined by a qualified actuary on the basis of triennial valuations. The actuarial valuation was made as at 31 December 2018 using the projected unit valuation method and the market value of the assets represented 100% of the market value of the liabilities.

The individual accounts of each of the participating employers need to reflect the obligation they have to the Scheme. The Scheme cannot identify each employer's share of the total Scheme assets. Therefore, it is not possible to use defined benefit accounting for an individual company. Accordingly, the Scheme is accounted for as if it is a defined contribution scheme.

The previous actuarial triennial valuation was completed as at 31 December 2021. The valuation of the Scheme revealed the Scheme is fully funded. The Trustees and the employers have agreed that an additional contribution of £57,200 per annum will be paid to cover the administrative cost of the Scheme. This amount will be paid into the Special Pension Account held by The Leprosy Mission International in equal monthly instalments from 1 January 2023 for a period of 3 years.

By agreement with the pension Trustees, The Leprosy Mission International has agreed to pay the above pension contribution into the Special Pension Account.

FRS102 required an entity that has entered into an agreement to reduce the historic deficit on a multiemployer pension scheme, to recognise the liability in accordance with FRS102 section 28.13 and 28.13A.

The most recent valuation of the Scheme was carried out with an effective date of 31 December 2021. This valuation revealed the Scheme was in surplus on the agreed Statutory Funding Objective basis agreed between the employers and the pension Scheme Trustees. As a result, no recovery plan was required. Therefore, the FRS102 liability as at 31 December 2024 is £nil (2023 - £nil).

In addition, the Charity has a trading subsidiary, which is included in the consolidated financial statements. The trading subsidiary also has a multi-employer pension scheme which is required to recognise its liability in accordance with FRS102 section 28.13 and 28.13A. At 31 December 2024, this liability is £nil (2023 - £nil). The impact of bringing these liabilities to account has resulted in a change in the value of the investment. The next actuarial valuation is due at 31 December 2024 and the results are expected by November 2025.

A Group Personal Pension Scheme (GPP) has been set up with AVIVA. Employers make a contribution of 10% of the monthly pensionable salary to AVIVA.

The Mission's pension cost for the year amounted to £148,254 (2023 - £142,795).

27 Related party transactions

TLM Trading Limited is a wholly owned subsidiary of The Leprosy Mission International, whose financial statements are publicly available from Companies House. (See note 4: Other trading activities for details of transactions between The Leprosy Mission International and TLM Trading Limited).

During the year the charity made a grant of £35,000 (2023 - £35,000) to TLM Trading Limited to promote development of artisan products by people affected by leprosy and disability groups.

During the year the charity made a loan of £100,000 to its subsidiary. At 31 December 2024, an amount of £101,979 (2023 - £30) was due to the parent company from its subsidiary through its inter-company account, which is settled in the year. There is no interest charged and no fixed repayment.

There were no other related party transactions in the current or previous accounting period.

THE LEPROSY MISSION INTERNATIONAL

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

28
Cash generated from operations
(Deficit)/surplus for the year
Adjustments for:
Investment income recognised in statement of financial activities
Foreign exchange differences
Fair value gains and losses on investments
Depreciation and impairment of tangible fixed assets
Movements in working capital:
Decrease in stocks
Decrease in debtors
(Decrease) in creditors
Cash (absorbed by)/generated from operations
29
Analysis of changes in net funds
The charity had no debt during the year.		 2024
£
(240,464)
(242,231)
121,532
433,705
161,130
10,089
33,340
(520,127)
(243,026)		 2023
£
1,202,317
(125,685)
(178,309)
(127,053)
194,921
67,652
145,111
(218,706)
960,248

30 Control

No one individual has overall control of the charitable company.